Streetbeat News

Price Targets

EDIT

Editas Medicine (NASDAQ:EDIT) has received 4 analyst ratings in the last quarter, with 3 being bullish, 1 indifferent, and none bearish. The average price target is $14.0, representing an implied upside from the current price of $9.84. The price target has increased by 16.67% over the past month. Analyst ratings are based on information from company activities and financials, and while they provide guidance, they are subjective opinions.

Portfolio Pulse from Benzinga Insights

December 12, 2023 | 4:00 pm

AMKR

Amkor Tech (NASDAQ:AMKR) received 4 analyst ratings in the last quarter, with 3 bullish and 1 indifferent, and no bearish ratings. The average price target is $34.25, representing an implied upside from the current price of $29.54. This target has decreased by 2.14% from the previous target of $35.00. Analysts' ratings are based on financial statements, company calls, and insider information, and are used to guide investors on stock performance.

Portfolio Pulse from Benzinga Insights

December 12, 2023 | 4:00 pm

GOGO

Roth MKM analyst Scott Searle has maintained a Buy rating on Gogo (NASDAQ:GOGO) but reduced the price target from $18.75 to $17.5.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 3:50 pm

MA

Jefferies analyst Trevor Williams has maintained a Buy rating on Mastercard (NYSE:MA) and increased the price target from $425 to $480. This adjustment reflects a positive outlook on Mastercard's future performance.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 3:47 pm

CASY

RBC Capital analyst Irene Nattel has maintained a 'Sector Perform' rating on Casey's General Stores (CASY) and increased the price target from $291 to $296.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 3:45 pm

BLBD

Craig-Hallum analyst Eric Stine has reaffirmed a Buy rating on Blue Bird (NASDAQ:BLBD) and increased the price target from $34 to $38, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 3:45 pm

NOTV

Craig-Hallum analyst Matt Hewitt has maintained a Buy rating on Inotiv (NASDAQ:NOTV) but has reduced the price target from $34 to $25.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 3:42 pm

ML

Craig-Hallum analyst George Sutton has reaffirmed a Buy rating on MoneyLion (NYSE:ML) and increased the price target from $30 to $55, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 3:40 pm

ORCL

Evercore ISI Group analyst Kirk Materne has maintained an Outperform rating on Oracle (NYSE:ORCL) but has reduced the price target from $135 to $130.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 3:38 pm

COST

Evercore ISI Group analyst Greg Melich has maintained an Outperform rating on Costco Wholesale (NASDAQ: COST) and increased the price target from $640 to $650.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 3:35 pm